You searched for lung cancer | Page 55 of 172

Quest Diagnostics to Acquire Haystack Oncology

After Quest acquires Haystack, Quest expects to adapt the MRD test developed at Haystack as the basis for new clinical lab services.

Posted by Andy Lundin | Apr 19, 2023 | Cancer |

Adela demonstrated the ability of its genome-wide methylome enrichment platform to detect a broad set of diverse cancers in early stages.

Posted by Chris Wolski | Apr 18, 2023 | Lung Cancer |

New data demonstrates Exai Bio’s novel RNA- and AI-based platform detected non-small cell lung cancer with high accuracy.

Posted by Andy Lundin | Apr 11, 2023 | Cancer |

Foundation Medicine and Bristol Myers Squibb are developing the FoundationOne CDx as a companion diagnostic for repotrectinib.

A simple blood draw can help determine if peptide receptor radionuclide therapy is effective in a patient with neuroendocrine cancer.